{
    "patient": {
        "Name": "Kimberly Berry",
        "DateOfBirth": "1945-08-15",
        "Sex": "Male",
        "Diagnosis": "Small cell carcinoma",
        "BodyPart": "Prostate",
        "Physician": "Dr. Linda Phillips",
        "TreatingInstitution": "Montgomery, Lynn and Stone"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Prostate",
            "CollectedDate": "2024-04-05",
            "ReceivedDate": "2024-04-07",
            "TumorPercentage": "59%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-04-10",
            "ReceivedDate": "2024-04-11"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "SDHB",
                "DNA Alteration": "c.487T>C",
                "GeneMutation": "p.S163P Nonsense-LOF",
                "VariantAlleleFraction": "7.0%"
            },
            {
                "Gene": "DICER1",
                "DNA Alteration": "c.5437G>A",
                "GeneMutation": "p.E1813K Nonsense-LOF",
                "VariantAlleleFraction": "30.62%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "MUTYH",
                "DNA Alteration": "c.1014G>C",
                "GeneMutation": "p.Y1225X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "4.74%"
            },
            {
                "Gene": "IDH1",
                "DNA Alteration": "c.394C>T",
                "GeneMutation": "p.E1813K Frameshift-LOF",
                "VariantAlleleFraction": "21.76%"
            },
            {
                "Gene": "CHD6",
                "DNA Alteration": "c.4800C>G",
                "GeneMutation": "p.I1600M Stopgain-LOF",
                "VariantAlleleFraction": "2.66%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "MYCN",
            "TP53",
            "ARID2",
            "ALDH2",
            "BRCA2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "42 m/Mb",
            "Tmbpercentile": "14%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "High"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}